Skip to main content

Table 1 Other studies with history of asthma, eosinophilia and no improvement after IVIg were the clues towards the vasculitic neuropathy, and it was supported by ANCA positivity in majority of cases

From: Eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) imitating Guillain–Barre syndrome (GBS): a case report

 

Study

Age

Presentation

Lab findings

NCS

Other

Treatment

Outcome

1

Ng et al. (1997)

58/M

Symmetric weakness, hyporeflexia, asthma

Eosinophilia, raised ESR, P-ANCA + ve

Mixed demyelinating polyneuropathy, multifocal absent F waves

Lung infiltrates

Steroids, cyclophosphamide, plasma exchange

Expired

2

Kevent et al. (1998)

57/M

Symmetric weakness, hyporeflexia

Raised ESR, P-ANCA + ve

Mixed demyelinating polyneuropathy, multifocal absent F waves

Nephritis

Steroids

Improved

3

Riva et al. (2008)

51/F

Asthma, nasal polyposis, symmetric weakness, hyporeflexia

Eosinophilia, raised ESR, P-ANCA -ve

Motor asymmetric axonal polyneuropathy, multifocal absent F waves

 

IVIg, steroids

Improved

4

Djukic et al. (2008)

74/M

Asthma, symmetric weakness, hyporeflexia

Eosinophilia

Mixed demyelinating polyneuropathy, multifocal absent F waves

 

Steroids, cyclophosphamide

Improved

5

Lemarroy et al. (2015)

36/F

Asthma, pansinusitis, purpura, symmetric weakness, hyporeflexia

Eosinophilia, raised ESR, P-ANCA + ve

Motor asymmetric axonal polyneuropathy

 

Steroids, cyclophosphamide

Improved

6

Bortolani et al. (2016)

68/F

Asthma, symmetric weakness, areflexia

Eosinophilia, P-ANCA + ve

Motor axonal polyneuropathy

 

Steroids

Improved

7

Yadav et al. (2017)

57/F

Asthma, symmetric weakness, hyporeflexia

Eosinophilia, proteinuria, P-ANCA + ve

Severe axonal and demyelinating polyneuropathy

Nephritis

Steroids, cyclophosphamide

Improved

8

Kim et al. (2018)

51/F

Asthma, asymmetric weakness, hyporeflexia, purpura

Eosinophilia, maxillary sinusitis, P-ANCA + ve

Sensory, motor, axonal, polyneuropathy

 

Steroids

Improved

  1. ESR erythrocyte sedimentation rate, P-ANCA perinuclear antineutrophil cytoplasmic antibodies, IVIg intravenous immunoglobulin